Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunityLucas A. Horn, Claudia Palena|Journal for ImmunoTherapy of Cancer|2020Cited by 96